248 related articles for article (PubMed ID: 29972633)
1. Drug-Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers.
Bashir B; Stickle DF; Chervoneva I; Kraft WK
Clin Transl Sci; 2018 Nov; 11(6):590-596. PubMed ID: 29972633
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients.
Mansell H; Shoker A; Alcorn J; Fenton ME; Tam JS; Semchuk W; Bashir B; Kraft WK; Yao S; Douketis JD
Clin Transl Sci; 2022 Jul; 15(7):1687-1697. PubMed ID: 35439353
[TBL] [Abstract][Full Text] [Related]
3. Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor.
Frost CE; Byon W; Song Y; Wang J; Schuster AE; Boyd RA; Zhang D; Yu Z; Dias C; Shenker A; LaCreta F
Br J Clin Pharmacol; 2015 May; 79(5):838-46. PubMed ID: 25377242
[TBL] [Abstract][Full Text] [Related]
4. Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit.
de Jonge H; Vanhove T; de Loor H; Verbeke K; Kuypers DR
Br J Clin Pharmacol; 2015 Sep; 80(3):548-59. PubMed ID: 26114223
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?
Hellwig T; Gulseth M
Ann Pharmacother; 2013 Nov; 47(11):1478-87. PubMed ID: 24259602
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.
Hulskotte E; Gupta S; Xuan F; van Zutven M; O'Mara E; Feng HP; Wagner J; Butterton J
Hepatology; 2012 Nov; 56(5):1622-30. PubMed ID: 22576324
[TBL] [Abstract][Full Text] [Related]
7. Relative Bioavailability of Apixaban Solution or Crushed Tablet Formulations Administered by Mouth or Nasogastric Tube in Healthy Subjects.
Song Y; Wang X; Perlstein I; Wang J; Badawy S; Frost C; LaCreta F
Clin Ther; 2015 Aug; 37(8):1703-12. PubMed ID: 26188837
[TBL] [Abstract][Full Text] [Related]
8. Physiologically-Based Pharmacokinetic Modeling for the Prediction of a Drug-Drug Interaction of Combined Effects on P-glycoprotein and Cytochrome P450 3A.
Otsuka Y; Choules MP; Bonate PL; Komatsu K
CPT Pharmacometrics Syst Pharmacol; 2020 Nov; 9(11):659-669. PubMed ID: 33030266
[TBL] [Abstract][Full Text] [Related]
9. Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant Recipients.
Vanhove T; Spriet I; Annaert P; Maertens J; Van Cleemput J; Vos R; Kuypers D
Ther Drug Monit; 2017 Feb; 39(1):77-82. PubMed ID: 27861314
[TBL] [Abstract][Full Text] [Related]
10. Inhibition effect of epigallocatechin-3-gallate on the pharmacokinetics of calcineurin inhibitors, tacrolimus, and cyclosporine A, in rats.
Huang X; Zhang R; Yang T; Wei Y; Yang C; Zhou J; Liu Y; Shi S
Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):121-134. PubMed ID: 33054444
[TBL] [Abstract][Full Text] [Related]
11. Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects.
Byon W; Nepal S; Schuster AE; Shenker A; Frost CE
J Clin Pharmacol; 2018 Jul; 58(7):965-971. PubMed ID: 29578609
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation.
Cirincione B; Kowalski K; Nielsen J; Roy A; Thanneer N; Byon W; Boyd R; Wang X; Leil T; LaCreta F; Ueno T; Oishi M; Frost C
CPT Pharmacometrics Syst Pharmacol; 2018 Nov; 7(11):728-738. PubMed ID: 30259707
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open-Label, Fixed-Sequence, Crossover Study.
Huang F; Voelk C; Trampisch M; Rowland L; Schultz A; Sabo JP
Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):84-93. PubMed ID: 29427400
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study.
Garonzik S; Byon W; Myers E; Li X; Marchisin D; Murthy B
Am J Cardiovasc Drugs; 2019 Dec; 19(6):561-567. PubMed ID: 31030414
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of P-gp and BCRP transporter-mediated drug-drug interactions of riociguat with direct oral anticoagulants.
Jacqueroux E; Mercier C; Margelidon-Cozzolino V; Hodin S; Bertoletti L; Delavenne X
Fundam Clin Pharmacol; 2020 Feb; 34(1):109-119. PubMed ID: 31411766
[TBL] [Abstract][Full Text] [Related]
16. An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects.
Bifano M; Adamczyk R; Hwang C; Kandoussi H; Marion A; Bertz RJ
Clin Drug Investig; 2015 May; 35(5):281-9. PubMed ID: 25896946
[TBL] [Abstract][Full Text] [Related]
17. Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects.
Upreti VV; Wang J; Barrett YC; Byon W; Boyd RA; Pursley J; LaCreta FP; Frost CE
Br J Clin Pharmacol; 2013 Dec; 76(6):908-16. PubMed ID: 23488672
[TBL] [Abstract][Full Text] [Related]
18. Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug-Drug Interactions with Potential Perpetrator Drugs.
Mikus G; Foerster KI; Schaumaeker M; Lehmann ML; Burhenne J; Haefeli WE
Clin Pharmacokinet; 2019 Sep; 58(9):1155-1163. PubMed ID: 30828771
[TBL] [Abstract][Full Text] [Related]
19. Characterization of efflux transporters involved in distribution and disposition of apixaban.
Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
[TBL] [Abstract][Full Text] [Related]
20. Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa.
Vakkalagadda B; Frost C; Byon W; Boyd RA; Wang J; Zhang D; Yu Z; Dias C; Shenker A; LaCreta F
Am J Cardiovasc Drugs; 2016 Apr; 16(2):119-27. PubMed ID: 26749408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
